Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
基本信息
- 批准号:9402967
- 负责人:
- 金额:$ 5.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlpha CellAnimal ModelAreaBiochemicalBiological ModelsBiomechanicsBiopsyCartilageCell CountChondrocytesClinicalClinical assessmentsCollagenDataDefectDevelopmentEngineeringEvaluationExhibitsFamily suidaeFiber OpticsFunctional disorderFundingGrowth FactorHarvestHistologicHumanHyaluronic AcidImageImplantIn VitroIndividualLeast-Squares AnalysisMagnetic Resonance ImagingMechanicsMethodsMiniature SwineModalityModelingModulusMolecularMolecular ProfilingMolecular StructureMonitorMusculoskeletalNear-Infrared SpectroscopyOperative Surgical ProceduresOptical MethodsOutcomePlayProductionPropertyProteoglycanProtocols documentationRegenerative MedicineRoleSeriesSpectroscopy, Fourier Transform InfraredTechniquesTechnologyTestingTherapeuticThickTimeTissue EngineeringTissuesTranslatingTranslationsWaterWorkX-Ray Computed Tomographybasecartilage repaircartilaginouscell typeclinical developmentclinical predictorsclinically relevantdesignimplantationin vivolaboratory experimentmechanical propertiesmicroCTmimeticsminimally invasivenovelpreimplantationrepairedscaffoldsubchondral bonesuccesstechnique developmenttissue regenerationtissue repair
项目摘要
Summary:
In spite of progress in understanding the pathophysiology of OA, there remain no definitive non-surgical
treatment options. Further, tissue engineering strategies designed to produce cartilage-mimetic materials have
seen only limited success; a significant impediment is the inability to fully assess the molecular structure of
developing tissue such that optimal constructs for implantation can be identified. Recently, we demonstrated
that the technique of non-destructive near infrared spectroscopy (NIRS) analysis can be utilized to assess the
primary molecular components of native and engineered cartilage. NIRS data correlates strongly to water and
matrix content (collagen and proteoglycan) in these tissues, and to mechanical properties. Having validated the
NIR technology for cartilage assessment, we propose to extend our studies to address an important emerging
area of musculoskeletal tissue engineering, identification of individual constructs suitable for clinical
implantation. These studies are based on the principle that increases in construct maturation prior to
implantation can be utilized to predict in vivo success. We hypothesize that maturation of the cartilaginous
matrix can be monitored by NIRS, and that the spectral data can be used as a predictor of clinical success. We
will address this in a series of in vitro and in vivo studies that evaluate construct development using NIRS
analysis. A cell-seeded hyaluronic acid (HA) scaffold, previously shown to be effective at promoting matrix
production and the development of functional material properties, will serve as the model system for
implantation into a porcine model of cartilage repair.
The proposed NIRS technology would establish a novel, non-destructive modality for pre-implantation
evaluation of developing engineered tissues for clinical implantation. There are currently no minimally-invasive
methods available for the clinical assessment of cartilage repair tissue maturation based on molecular
signatures. The development of clinically-relevant optical methods to evaluate full-depth composition of tissues
in a large animal model will provide a strong underpinning for translation of this technique into the clinical
setting. Such analyses would also represent a fundamentally new and powerful approach for evaluating and
guiding cartilage therapeutics. The possibility of one non-destructive modality that can be used in vitro during
laboratory experiments of developing tissues to assess composition and identify constructs for implantation, as
well as after the constructs are implanted clinically, would indeed be a powerful technique that could play a
central role in the regenerative medicine field.
总结:
尽管在理解OA的病理生理学方面取得了进展,但仍然没有明确的非手术治疗方法。
治疗方案。此外,设计用于产生软骨模拟材料的组织工程策略已经
只看到有限的成功;一个重大的障碍是无法充分评估的分子结构
发育组织,从而可以鉴定用于植入的最佳构建体。最近,我们展示了
非破坏性近红外光谱(NIRS)分析技术可用于评估
天然和工程软骨的主要分子成分。近红外光谱数据与水和
这些组织中的基质含量(胶原蛋白和蛋白聚糖)以及机械性能。在确认了
近红外技术的软骨评估,我们建议扩大我们的研究,以解决一个重要的新兴
肌肉骨骼组织工程领域,适合临床的个体构建物的鉴定
置入这些研究是基于这样的原则,即在构建体成熟之前,
植入可用于预测体内成功。我们假设软骨的成熟
基质可以通过NIRS监测,并且光谱数据可以用作临床成功的预测因子。我们
将在一系列体外和体内研究中解决这一问题,这些研究使用NIRS评估构建体的发展
分析.一种细胞接种的透明质酸(HA)支架,以前被证明是有效的促进基质
生产和功能材料性能的发展,将作为模型系统,
植入到软骨修复的猪模型中。
提出的近红外光谱技术将建立一种新的,非破坏性的模式,为植入前
评价开发用于临床植入的工程化组织。目前还没有微创的
可用于基于分子生物学的软骨修复组织成熟的临床评估的方法
签名.临床相关光学方法的发展,以评估组织的全深度组成
在大型动物模型中的应用将为该技术转化为临床提供强有力的基础,
设置.这种分析也将是一种全新的、强有力的方法,
指导软骨治疗。一种非破坏性方式的可能性,可以在体外使用,
组织发育实验室实验,以评估组成并鉴定用于植入的结构,如
以及在临床上植入结构后,确实是一种强大的技术,可以发挥
在再生医学领域的核心作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy Pleshko其他文献
Nancy Pleshko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy Pleshko', 18)}}的其他基金
Non-Destructive Spectroscopic Assessment of Bone Water at Microscopic Resolution
微观分辨率下骨水的无损光谱评估
- 批准号:
9308435 - 财政年份:2017
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
- 批准号:
8264380 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
- 批准号:
9926711 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
- 批准号:
9185759 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
- 批准号:
9326141 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
- 批准号:
7901081 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
- 批准号:
8088040 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
- 批准号:
7559112 - 财政年份:2009
- 资助金额:
$ 5.7万 - 项目类别:
Infrared fiber optic imaging of degenerative cartilage
退行性软骨的红外光纤成像
- 批准号:
7934494 - 财政年份:2002
- 资助金额:
$ 5.7万 - 项目类别:
Infrared fiber optic imaging of degenerative cartilage
退行性软骨的红外光纤成像
- 批准号:
7664497 - 财政年份:2002
- 资助金额:
$ 5.7万 - 项目类别:
相似海外基金
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 5.7万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 5.7万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10427574 - 财政年份:2022
- 资助金额:
$ 5.7万 - 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
- 批准号:
10609909 - 财政年份:2022
- 资助金额:
$ 5.7万 - 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
- 批准号:
10607392 - 财政年份:2022
- 资助金额:
$ 5.7万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10675646 - 财政年份:2022
- 资助金额:
$ 5.7万 - 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
- 批准号:
457552 - 财政年份:2021
- 资助金额:
$ 5.7万 - 项目类别:
Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
- 批准号:
10331361 - 财政年份:2020
- 资助金额:
$ 5.7万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 5.7万 - 项目类别:
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
定义 2 型糖尿病的 α 细胞 PC1/3 表达调控
- 批准号:
10376866 - 财政年份:2020
- 资助金额:
$ 5.7万 - 项目类别:














{{item.name}}会员




